Argitalpenak (143) Luis María Máiz Carro argitalpenak

2024

  1. Aerosolized Ampicillin in a Patient With Recurrent Respiratory Infections

    Archivos de Bronconeumologia

  2. Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

    The European respiratory journal, Vol. 63, Núm. 6

  3. Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)

    Journal of Allergy and Clinical Immunology, Vol. 153, Núm. 6, pp. 1553-1562

  4. Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

    The European respiratory journal, Vol. 63, Núm. 4

  5. Reliability of blood eosinophil count in steady-state bronchiectasis

    Pulmonology

  6. The cardiomyopathy of cystic fibrosis: a modern form of Keshan disease

    Frontiers in Cardiovascular Medicine, Vol. 11

2023

  1. Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries

    Archivos de Bronconeumologia, Vol. 59, Núm. 10, pp. 688-690

  2. Incidence of tumour pathology in patients with cystic fibrosis in the Community of Madrid

    Revista de Patologia Respiratoria

  3. Probiotics and Respiratory Infections

    Open Respiratory Archives

  4. Safety and effectiveness of treatment with elexacaftor, tezacaftor and ivacaftor in adults with cystic fibrosis

    Medicina Clinica, Vol. 161, Núm. 8, pp. 338-341

  5. The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity: The Effect of Inhaled Corticosteroids

    Chest, Vol. 164, Núm. 3, pp. 606-613

  6. The role of precision medicine in bronchiectasis: emerging data and clinical implications

    Expert Review of Respiratory Medicine, Vol. 17, Núm. 4, pp. 279-293

  7. What Have We Learned About Bronchiectasis From RIBRON (Spanish Bronchiectasis Registry)?

    Archivos de Bronconeumologia

2022

  1. Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes

    Biomedicines, Vol. 10, Núm. 5

  2. Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis

    Journal of Clinical Medicine, Vol. 11, Núm. 14

  3. Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence

    Infection and Drug Resistance, Vol. 15, pp. 7271-7292

  4. Peripheral Neutrophil-to-Lymphocyte Ratio in Bronchiectasis: A Marker of Disease Severity

    Biomolecules, Vol. 12, Núm. 10

  5. Safety and tolerability of inhaled antibiotics in patients with bronchiectasis

    Pulmonary Pharmacology and Therapeutics, Vol. 72

  6. Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study

    Biomedicines, Vol. 10, Núm. 2

  7. The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives

    Microorganisms, Vol. 10, Núm. 4